<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="target/tutorial/zika/PMC4495344/results/species/binomial/results.xml">
  <result pre="Malaria vaccine development has largely focused on " exact="Plasmodium falciparum" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium falciparum" post="; however, a reawakening to the importance of Plasmodium vivax has spurred efforts to develo" name="binomial"/>
  <result pre="t has largely focused on Plasmodium falciparum; however, a reawakening to the importance of " exact="Plasmodium vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=" has spurred efforts to develop vaccines against this difficult to treat and at times severe form o" name="binomial"/>
  <result pre="tutes a significant proportion of human malaria cases worldwide. The almost complete dependence of " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=" red blood cell invasion on the interaction of the P. vivax Duffy-binding protein region II " name="binomial"/>
  <result pre="he almost complete dependence of P. vivax red blood cell invasion on the interaction of the " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=" Duffy-binding protein region II (PvDBP_RII) with the human Duffy antigen receptor for chemokines (" name="binomial"/>
  <result pre="eptor for chemokines (DARC) makes this antigen an attractive vaccine candidate against blood-stage " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=". Here, we generated both preclinical and clinically compatible adenoviral and poxviral vectored va" name="binomial"/>
  <result pre="adjuvants). Antibodies induced by these regimes were found to bind to native parasite antigen from " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=" infected Thai patients and were capable of inhibiting the binding of PvDBP_RII to its receptor DAR" name="binomial"/>
  <result pre="and MVA vectors have been quickly translated into human clinical trials for numerous antigens from " exact="P. falciparum" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium falciparum" post=" as well as a growing number of other pathogens. The vectors reported here are immunogenic in small" name="binomial"/>
  <result pre="ease remain sobering. Historically, vaccine development efforts have almost exclusively focused on " exact="Plasmodium falciparum" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium falciparum" post=" – the major causative agent of malarial disease in sub-Saharan Africa ( 1 &lt;/s" name="binomial"/>
  <result pre="ial disease in sub-Saharan Africa ( 1 ). A second species of parasite, " exact="Plasmodium vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=", is the most widespread geographically and thus constitutes a significant proportion of human mala" name="binomial"/>
  <result pre=" 2 ), revised estimates suggest 2.5 billion people are living at risk of " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=" infection in the Americas, as well as Central and South-East Asia ( 3 " name="binomial"/>
  <result pre="cine Technology Roadmap to 2030 ( 5 ) now recognizes the importance of " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=" malaria and calls for a vaccine to achieve 75% efficacy over 2 years – equally weighted with P." name="binomial"/>
  <result pre="x malaria and calls for a vaccine to achieve 75% efficacy over 2 years – equally weighted with " exact="P. falciparum" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium falciparum" post=" in an era of renewed political will to control and eradicate this devastating disease. " name="binomial"/>
  <result pre="nization. In the past, a small handful of pre-erythrocytic and sexual-stage vaccine candidates for " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=", based on the PvCSP and Pvs25 antigens respectively, have entered early phase clinical testing as " name="binomial"/>
  <result pre=", mainly focusing on merozoite ligands involved in erythrocyte invasion, are under development for " exact="P. falciparum" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium falciparum" post=" ( 10 ) but, as yet, no clinical trials of equivalent P. vivax " name="binomial"/>
  <result pre=". falciparum ( 10 ) but, as yet, no clinical trials of equivalent " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=" blood-stage candidate vaccines have been reported ( 11 ). " name="binomial"/>
  <result pre="urface of the host’s red blood cell (RBC) ( 12 ). Invasion of RBCs by " exact="P. vixax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vixax" post=" is restricted to CD71 + reticulocytes ( 13 ) and commonly " name="binomial"/>
  <result pre="+ reticulocytes ( 13 ) and commonly uses the interaction of the " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=" Duffy-binding protein (PvDBP) with the human Duffy antigen receptor for chemokines (DARC/Fy) ( &lt;s" name="binomial"/>
  <result pre="ef=&quot;#B14&quot;&gt;14 ). Notably, Duffy-negative individuals appear to be protected from blood-stage " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=" infection, an observation first reported by Miller et al. in 1976 ( 15 &lt;/sup" name="binomial"/>
  <result pre="s ( 16 ), and associated geographically with sub-Saharan Africa where " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=" is largely absent ( 17 ). Of note, there have been reports of P. v" name="binomial"/>
  <result pre="vax is largely absent ( 17 ). Of note, there have been reports of " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=" isolates that can invade Duffy-negative cells ( 18 ), with recent seq" name="binomial"/>
  <result pre="e invasion into Duffy-negative cells, and further highlight the importance of the PvDBP antigen in " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=" infection. " name="binomial"/>
  <result pre="s. All parasites have at least one EBL, and in many cases these lead to redundancy, as observed in " exact="P. falciparum" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium falciparum" post=" ( 20 ). In the case of P. vivax, the PvDBP gene and its paralo" name="binomial"/>
  <result pre="edundancy, as observed in P. falciparum ( 20 ). In the case of " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=", the PvDBP gene and its paralog are known to exist ( 19 ), and geneti" name="binomial"/>
  <result pre=" exist ( 19 ), and genetic knockout of the orthologous simian malaria " exact="P. knowlesi" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium knowlesi" post=" DBPα gene prevents invasion of Duffy-positive erythrocytes in vitro ( &lt;a href=&quot;#B21&quot;" name="binomial"/>
  <result pre=" 23 , 24 ), and those raised against the " exact="P. knowlesi" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium knowlesi" post=" DBPα ortholog can block RBC invasion by this parasite in vitro ( 25 &lt;" name="binomial"/>
  <result pre="ding inhibitory antibodies against PvDBP_RII have been shown to be associated with reduced risk of " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=" infection in children residing in an endemic area, as well as lower P. vivax parasite densi" name="binomial"/>
  <result pre="educed risk of P. vivax infection in children residing in an endemic area, as well as lower " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=" parasite densities following infection ( 26 ). Thus, to date, the PvD" name="binomial"/>
  <result pre=" ). Thus, to date, the PvDBP_RII adhesin remains the most promising subunit vaccine target against " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=" merozoites; however, this antigen has never been progressed to clinical trials and, consequently, " name="binomial"/>
  <result pre="href=&quot;#B32&quot;&gt;32 ). It has also been shown to be safe and immunogenic for the delivery of the " exact="P. falciparum" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium falciparum" post=" blood-stage antigens merozoite surface protein 1 (PfMSP1) and apical membrane antigen 1 (PfAMA1) i" name="binomial"/>
  <result pre="n adjuvant. Antibodies induced by these regimes were found to bind to native parasite antigen from " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=" infected patients and were capable of inhibiting the binding of PvDBP_RII to its receptor DARC " name="binomial"/>
  <result pre="ng sequence of region II of the Duffy-binding protein from the Salvador I ( SalI) strain of " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=", amino acids (αα) 194–521 (GenBank Accession #DQ156512). The PvDBP_RII construct was codon optimiz" name="binomial"/>
  <result pre="Unless otherwise stated, all studies used rDBP produced in " exact="Escherichia coli" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Escherichia coli" post=" and purified as previously described ( 42 ). Endotoxin levels were me" name="binomial"/>
  <result pre="rix containing phosphatidyl choline phospholipid, cholesterol, and saponins purified from the tree " exact="Quillaja saponaria" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Quillaja saponaria" post=" Molina – a mixture of Matrix A and Matrix C (containing the QS7 and QS21 fractions respectively) p" name="binomial"/>
  <result pre=" " exact="Plasmodium vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post="-infected blood was collected from malaria patients attending the clinics of the Shoklo Malaria Res" name="binomial"/>
  <result pre="025; University of Oxford, Centre for Clinical Vaccinology and Tropical Medicine, Oxford, UK). The " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post="-infected erythrocytes were cultured to the late schizont stage prior to being concentrated and was" name="binomial"/>
  <result pre="rious preclinical animal models to induce functional antigen-specific antibody responses targeting " exact="P. falciparum" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium falciparum" post=" antigens, such as PfMSP1, PfAMA1, PfRH5, and Pfs25 ( 30 – &lt;a h" name="binomial"/>
  <result pre="nd its natural ligand, the Fy antigen/DARC. In the absence of an easily available and standardized " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=" assay of growth inhibition activity to assess anti-merozoite antibody function in vitro, a " name="binomial"/>
  <result pre="ot confirm that vaccine-induced antibodies are capable of recognition of native antigen within the " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=" parasite. In order to assess this, indirect IFAs were performed using slides prepared from the blo" name="binomial"/>
  <result pre="ite. In order to assess this, indirect IFAs were performed using slides prepared from the blood of " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=" infected Thai patients. Slides were probed with serum taken 2 weeks after the final vaccination fr" name="binomial"/>
  <result pre="49&quot;&gt;49 ). Serum from these rabbits, but not from vector immunized controls, also recognized " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=" schizonts with a punctate staining pattern (Figure 5C). " name="binomial"/>
  <result pre="eport that identified the Duffy blood group antigen as a critical determinant of susceptibility to " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=" malaria ( 15 ). However, despite great strides in our understanding a" name="binomial"/>
  <result pre="inical trials ranging from Phase I–III, as vaccine candidates against numerous pathogens including " exact="P. falciparum" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium falciparum" post=" malaria ( 33 , 60 ), HIV-1 ( &lt;a h" name="binomial"/>
  <result pre=" HIV-1 ( 61 ), hepatitis C virus ( 62 ), " exact="Mycobacterium tuberculosis" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Mycobacterium tuberculosis" post=" ( 63 ), influenza virus ( 64 ), and Ebol" name="binomial"/>
  <result pre=" assessed for their ability to raise cellular and humoral immune responses against the blood-stage " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=" antigen PvDBP_RII in mice and rabbits. Moreover, immune responses elicited by viral vectored vacci" name="binomial"/>
  <result pre=" recombinant MVA. In recent years, ChAd63 and markerless MVA vectors encoding target antigens from " exact="P. falciparum" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium falciparum" post=" have been routinely progressed to Phase I/II clinical trials ( 44 , " name="binomial"/>
  <result pre="sponse directed against one dominant, and at least two sub-dominant, epitopes. Natural exposure to " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=" ( 73 ), as well as immunization of rhesus macaques with PvDBP_RII pro" name="binomial"/>
  <result pre="720. The potential role of the equivalent human isotypes IgG1 and IgG3 in natural immunity against " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=" remains unclear, although these subclasses tend to dominate in the natural response to merozoite a" name="binomial"/>
  <result pre=" although these subclasses tend to dominate in the natural response to merozoite antigens for both " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=" and P. falciparum ( 74 , 75 ) and" name="binomial"/>
  <result pre="lasses tend to dominate in the natural response to merozoite antigens for both P. vivax and " exact="P. falciparum" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium falciparum" post=" ( 74 , 75 ) and likely mediate effector " name="binomial"/>
  <result pre="tibodies induced here in mice and rabbits by the AM regime were also capable of recognizing native " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=" parasite antigen as assessed by IFA using freshly isolated parasites from Thai patients, consisten" name="binomial"/>
  <result pre="parasites from Thai patients, consistent with other studies using viral vectors to deliver leading " exact="P. falciparum" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium falciparum" post=" antigens in rabbits and humans ( 31 , 44 " name="binomial"/>
  <result pre="ntibodies can recognize native parasite isolates. Studies of naturally acquired immunity following " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=" exposure have reported the induction of strain-specific immunity ( 82 " name="binomial"/>
  <result pre="ctive anti-PvDBP_RII antibodies that recognize and block binding of diverse PvDBP_RII domains from " exact="P. vivax" xpath="/html[1]/body[1]/div[1]/div[6]/p[7]" match="Plasmodium vivax" post=" field isolates have been reported albeit at low frequency ( 26 ). Thi" name="binomial"/>
  <result pre=" immune responses in humans that cross-react with diverse variants, and provide protection against " exact="P. vivax" match="Plasmodium vivax" post=" blood-stage infections, will be important future questions for clinical trials with first-generati" name="binomial"/>
 </snippets>
</snippetsTree>
